Sodium-glucose co-transporter-2 inhibitor therapy and unmasking of JAK2-mutated myeloproliferative neoplasm: A Mayo Clinic series of nine consecutive cases.

American journal of hematology 2023 Jul 20

Sodium-glucose co-transporter-2 inhibitor therapy and unmasking of JAK2-mutated myeloproliferative neoplasm: A Mayo Clinic series of nine consecutive cases.

Related Questions

Is there any benefit of using aspirin to mitigate VTE risk in testosterone-induced polycythemia?

New answer by at Mount Sinai (November 1, 2024)

Helpful to see a colleague‘s comments about a practice pattern I have picked up.

Read more (2 Answers available)